Stockscreener 앱 받기
25.30
3.05%
-0.795
전일 마감가:
$26.10
열려 있는:
$25
하루 거래량:
541.83K
Relative Volume:
0.48
시가총액:
$1.39B
수익:
$199.89M
순이익/손실:
$52.48M
주가수익비율:
29.77
EPS:
0.85
순현금흐름:
$61.15M
1주 성능:
-20.00%
1개월 성능:
-1.00%
6개월 성능:
+162.77%
1년 성능:
+93.17%
1일 변동 폭
$24.66
$25.55
1주일 범위
$24.50
$32.59
52주 변동 폭
$5.35
$38.69
Stoke Therapeutics Inc Stock (STOK) Company Profile
명칭
Stoke Therapeutics Inc
전화
781-430-8200
주소
45 WIGGINS AVENUE, BEDFORD, MA
STOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STOK
Stoke Therapeutics Inc
|
25.30 | 1.43B | 199.89M | 52.48M | 61.15M | 0.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.62 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.70 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.03 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Stoke Therapeutics Inc Stock (STOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-18 | 개시 | Jefferies | Buy |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-03-26 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-07-25 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-05-01 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-26 | 재개 | Canaccord Genuity | Buy |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-24 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-01-31 | 개시 | Jefferies | Buy |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-11-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-18 | 개시 | UBS | Neutral |
| 2021-05-10 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-10 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-12-11 | 재확인 | Needham | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-09-29 | 개시 | Needham | Buy |
| 2019-12-18 | 개시 | Wedbush | Outperform |
| 2019-11-12 | 개시 | BTIG Research | Buy |
| 2019-10-25 | 개시 | H.C. Wainwright | Buy |
| 2019-07-15 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Credit Suisse | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
모두보기
Stoke Therapeutics Inc 주식(STOK)의 최신 뉴스
JPMorgan Chase & Co. Raises Stoke Therapeutics (NASDAQ:STOK) Price Target to $25.00 - MarketBeat
What technical models suggest about Stoke Therapeutics Inc.’s comebackJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Can Stoke Therapeutics Inc. stock resist sector downturnsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Using portfolio simulators with Stoke Therapeutics Inc. includedJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Stoke Therapeutics (STOK): JP Morgan Raises Price Target, Mainta - GuruFocus
Live market analysis of Stoke Therapeutics Inc.Weekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Why Stoke Therapeutics Inc. stock attracts high net worth investorsQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Can Stoke Therapeutics Inc. stock sustain institutional interestMarket Activity Summary & Daily Momentum Trading Reports - newser.com
What insider trading reveals about Stoke Therapeutics Inc. stockGold Moves & High Accuracy Trade Alerts - newser.com
Is Stoke Therapeutics Inc. stock a good choice for value investorsQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
Does Stoke Therapeutics Inc. show high probability of reboundWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Will Stoke Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Stoke Therapeutics Shares Plunge Following Clinical Trial Data Release - AD HOC NEWS
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 6.3%Should You Sell? - MarketBeat
Stoke Therapeutics Inc expected to post a loss of 57 cents a shareEarnings Preview - TradingView
Exit strategy if you’re trapped in Stoke Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Stoke Therapeutics, Inc. (STOK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Total debt per share of Stoke Therapeutics, Inc. – BER:0GT - TradingView
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates - Yahoo Finance
Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - Nasdaq
Stoke Therapeutics (STOK) Projected to Post Earnings on Tuesday - MarketBeat
Will Stoke Therapeutics Inc. stock maintain dividend yieldExit Point & AI Forecast for Swing Trade Picks - Fundação Cultural do Pará
Why Stoke Therapeutics Inc. stock is popular among millennialsTrade Performance Summary & Stock Market Timing Techniques - fcp.pa.gov.br
Take Profit: Is Stoke Therapeutics Inc. stock a good choice for value investorsTrade Risk Summary & Target Return Focused Stock Picks - fcp.pa.gov.br
Stoke Therapeutics Inc (STOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
0.86%
자본화:
|
볼륨(24시간):